L26/P-520 Is there an association between early pregnancy serum hormone levels and live birth rates after natural cycle frozen-thawed blastocyst transfer?
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C. Roelens und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Are serum progesterone and estradiol levels on first pregnancy test (PT) day associated with live birth rates (LBR) after natural cycle frozen-thawed blastocyst transfer (NC-FET)? Summary answer Serum progesterone, estradiol, and their interaction on PT day were associated with live birth after NC-FET, enabling development of a predictive model. What is known already FET use has expanded globally due to vitrification and broader freeze-all indications. In true NC-FET, low progesterone (<10 ng/mL) prior to blastocyst transfer has been linked to poorer outcomes. Prospective multicenter data further support the importance of adequate endogenous progesterone, in cycles relying solely on endogenous progesterone, LBR increased with rising transfer day progesterone levels (up to 53.9%), peaking around 20.3 ng/mL in both true NC-FET and modified NC-FET. However, progesterone and estradiol concentrations on pregnancy test day in NC-FET remain largely unexplored, despite evidence from artificial cycle FET (AC-FET) linking low pregnancy test day progesterone to poorer pregnancy outcomes. Study design, size, duration A retrospective cohort study was conducted at a tertiary, university-affiliated referral center and included 251 unique pregnant patients who underwent blastocyst transfer in a NC between November 2020 and March 2024. The primary objective was to assess the association between serum progesterone and estradiol levels measured on the first pregnancy test (9-12 days post-transfer), including their interaction, and the probability of live birth. Additionally, we aimed to develop a multivariable prediction model for live birth. Participants/materials, setting, methods The study included all patients with BMI <35 kg/m² undergoing true or modified NC-FET, with or without luteal phase support (LPS) started at FET, who had a positive (>10IU/L) serum hCG test (9-12 days post-transfer). Cycles using oocyte donation or IVM were excluded, as were patients with recurrent early pregnancy loss (≥2 losses <10 weeks) or uterine pathology. Only cycles with in-house progesterone and estradiol measurements on FET and PT days were included. Main results and the role of chance A total of 251 NC-FET pregnancies were analyzed (mean age 34.0±4.4 years; BMI 24.7±4.6 kg/m²). Mean progesterone levels were 14.5±6.2 µg/L on FET day and 26.0±9.9 µg/L on PT day, while mean estradiol was 257.5±118.7 ng/L. Low progesterone on FET day occurred in 18.3% and prompted supplementation, while 26.3% received LPS regardless of progesterone levels, mainly with vaginal progesterone (80.2%) or oral dydrogesterone (8.9%). Binned analyses showed increasing LBR with higher progesterone and estradiol concentrations on PT day, with a plateau around 21 µg/L for progesterone and around 260 ng/L for estradiol. In multivariable analysis, PT day progesterone (OR 1.15, 95% CI: 1.06-1.24, p = 0.001) and estradiol (OR 1.01, 95% CI: 1.01-1.02, p = 0.002) were independently associated with LBR. Older age at cryopreservation, day 6 blastocyst transfer, and tubal factor infertility were negatively associated with LBR. The use of LPS started at FET did not demonstrate predictive value. A logistic regression model predicting live birth included progesterone, estradiol and their interaction, age, day of cryopreservation, and tubal and genetic indications was significant (χ²=49.74, p < 0.001), explained 27.5% of the variance (Nagelkerke R²=0.275), and correctly classified 80.0% of cases. Discrimination was acceptable (AUC 0.776); the optimal probability threshold was 0.84 (sensitivity 55%, specificity 90%). Limitations, reasons for caution This retrospective single-center analysis is subject to selection bias and LPS heterogeneity. The sample size was limited because only pregnancies with in-house testing were eligible, potentially affecting generalizability. Although uniform hormone quantification reduced assay variability, the predictive model requires external validation and prospective confirmation before clinical implementation. Wider implications of the findings This study suggests that combined progesterone and estradiol levels on pregnancy test day may inform individualized live birth prediction after natural-cycle FET. The findings challenge single-hormone cut-offs and support integrated hormonal interpretation. If prospectively validated, the model could guide targeted progesterone support to optimize outcomes. Trial registration number No
Zitieren
APA
Roelens, C., Aouragh, T., Ranisavljevic, N., Landuyt, L. V., Vos, M. D., Tournaye, H., Blockeel, C., & Mackens, S. (2026). L26/P-520 Is there an association between early pregnancy serum hormone levels and live birth rates after natural cycle frozen-thawed blastocyst transfer?. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.853
Vancouver
Roelens C, Aouragh T, Ranisavljevic N, Landuyt LV, Vos MD, Tournaye H, et al. L26/P-520 Is there an association between early pregnancy serum hormone levels and live birth rates after natural cycle frozen-thawed blastocyst transfer?. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.853
BibTeX
@article{Roelens2026,
author = {Roelens, C. and Aouragh, T. and Ranisavljevic, N. and Landuyt, L. Van and Vos, M. De and Tournaye, H. and Blockeel, C. and Mackens, S.},
title = {L26/P-520 Is there an association between early pregnancy serum hormone levels and live birth rates after natural cycle frozen-thawed blastocyst transfer?},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.853}
}
EUVIMED